The United States Tumor Profiling Market is projected to surge from US$ 3.41 billion in 2024 to US$ 7.44 billion by 2033, ...

The Colorado firm is expanding its partnerships, outreach efforts, technology applications, and sales force for its oncology screening and monitoring test business.

Novel nephron organoids that can be fine-tuned to represent the proximal convoluted tubule or loop of Henle have been ...

Misunderstandings about who needs screening and how often may be why some women skip mammograms. Here are eight claims about ...

Co-Diagnostics, Inc. (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will host a ...

ESMO 2025 showcased the breadth and urgency of breast cancer research, which remains one of the most diagnosed malignancies ...

The paper features a comprehensive evaluation of data, including disease control rate, overall survival, immune activation, ...